U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

1987
121

Targets

Primary TargetPharmacologyConditionPotency
Peroxisome proliferator-activated receptor gamma
118
Activator
1,447
Lysophosphatidic acid receptor 1
4
Antagonist
2,849
 10.0 µM [IC50]
Lysophosphatidic acid receptor 2
4
Antagonist
2,849
 5.5 µM [IC50]
Lysophosphatidic acid receptor 3
4
Antagonist
2,849
 3.1 µM [IC50]
All of the following components must be present:
ALTEPLASE SINGLE CHAIN
ALTEPLASE TWO CHAIN PROTEIN
ACTIVE MOIETY
ALTEPLASE
Definition References
(2)
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966